載入...
Mutation EthA(W21R) confers co-resistance to prothionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
Ethionamide (ETA) and prothionamide (PRO) are interchangeably used in tuberculosis (TB) chemotherapy regimens. Subtle discrepancies between biochemical and genetic information on the modes of sensitivity and resistance of isoniazid (INH) and ETA warrants further studies. We report a new mutation – E...
Na minha lista:
| 發表在: | Infect Drug Resist |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6005328/ https://ncbi.nlm.nih.gov/pubmed/29942141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S163965 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|